Nature Communications / LinkedIn · Jul 2026
Ataraxis said Nature Communications published a positive clinical validation study of Ataraxis Breast; the company highlighted results across 8,161 patients and 15 cohorts.
Company research
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Overview
Ataraxis AI is a New York-based AI precision-medicine company spun out of NYU that builds multimodal oncology tools to predict cancer recurrence and treatment benefit. Its flagship product is Ataraxis Breast, a breast-cancer prognostic/predictive suite built on the Kestrel/Falcon pathology foundation-model stack. I did not surface a public GitHub or X account in the sources reviewed.
Primary product
Ataraxis Breast (including RISK, CTX, and NEO modules)
Founded
2023
Headquarters
New York, New York, United States
Team size
30-40
Work style
Flexible
Industry
Artificial Intelligence
Sub-industry
Precision medicine / oncology diagnostics
Offices
169 Madison Ave, New York, NY 10016, United States (HQ)
Distributed workforce across the United States, Poland, and Belgium
Business model
B2B clinical diagnostics
research collaborations / translational AI
Funding
Stage
Series A
Total raised
$24.4M
Latest round
Series A · Mar 2025
Latest amount
$20.4M
Mar 2025 · AIX Ventures
Oct 2024 · Giant Ventures and Obvious Ventures
Oct 2024 · Giant Ventures
People & investors
Leadership
Chief Executive Officer & Co-Founder
Chief Scientific Officer & Co-Founder
Chief of Staff
Work & culture
Research-heavy and physician-scientist-led, with a flat organizational structure that emphasizes initiative and results; the team blends scientists, engineers, and clinicians.
Work style
Flexible
Compensation
Public job postings show a Software Engineer role at $100K-$180K plus equity; other commercial roles mention base salary plus variable commission, equity, and benefits.
Benefits
Health insurance
401(k)
Generous parental leave
Generous PTO
Paid sick days
Free snacks and drinks
Remote work program
Product & market
Differentiators
- —AI-native prognostic and predictive testing rather than a purely genomic assay
- —Multimodal use of pathology slides plus clinical data
- —Foundation models trained on hundreds of millions of pathology images
- —Fast turnaround time (about 1 hour to less than 24 hours, depending on the page/source)
- —No extra tissue exhaustion or additional histology prep required
- —Causal inference layer (Tau) for individualized treatment-benefit estimation
- —Extends across multiple breast-cancer subtypes
Technology
Python
PyTorch
Hugging Face
OpenAI
Google Cloud Platform
Docker
Kubernetes
React
TypeScript
Flask
PostgreSQL
SQLAlchemy
Vercel
GitHub Actions
Terraform
Playwright
Jupyter
Salesforce
HubSpot
Segment
Customers
Oncologists
Breast cancer centers
Health systems
NCI-designated cancer centers
Community clinics
Competitors
Oncotype DX
PAIGE
Ibex
Onc.ai
Tempus
Natera
Exact Sciences
Scale & contact
Estimated revenue
approximately $2.8M annually
Estimated monthly visits
7.8K
Traffic estimate as of Jul 2026
Latest news
Ataraxis AI · May 2026
Ataraxis said it would present new predictive data at ASCO 2026, including its first clinical validation in a Phase III randomized controlled trial and prospective-trial results for Ataraxis Breast.
Ataraxis AI · Apr 2026
A technical blog post explaining Falcon, Ataraxis’ 1.1B-parameter pathology foundation model trained on 2B patches from 250,000+ whole-slide images, and its improved performance over Kestrel.
Business Wire · Apr 2026
Launch announcement for Ataraxis Breast NEO, which estimates likelihood of pathologic complete response after neoadjuvant therapy in early-stage breast cancer.
Ataraxis AI · Apr 2026
Ataraxis launched Breast NEO to estimate pathologic complete response after neoadjuvant therapy in early-stage breast cancer.
Jobs and careers at Ataraxis
12 jobs at Ataraxis
Client Success Specialist
Remote
Commercial
USA (Everywhere); United States
2d ago
Remote
Full-time
Head of Business Development
Remote
Commercial
New York (Remote Possible); New York, New York, United States
3d ago
Remote
Full-time
Scientific Engagement
Remote
Medical
Remote; United States
1mo ago
Remote
Full-time
Member of Technical Staff, Bayesian Statistics
On-site
AI
New York HQ; New York, New York, United States
1mo ago
On-site
Full-time
Member of Technical Staff, Causality
On-site
AI
New York HQ; New York, New York, United States
1mo ago
On-site
Full-time
Member of Technical Staff, Survival Analysis
On-site
AI
New York HQ; New York, New York, United States
1mo ago
On-site
Full-time
Member of Technical Staff, Principal Biostatistician
On-site
AI
New York HQ
1mo ago
On-site
Full-time
Member of Technical Staff, Research Engineer
On-site
AI
New York HQ
2mo ago
On-site
Full-time
Member of Technical Staff, Computational Pathology
On-site
AI
New York HQ
2mo ago
On-site
Full-time
Member of Technical Staff, Foundation Models
On-site
AI
New York HQ
2mo ago
On-site
Full-time
Member of Technical Staff, Translational Science
On-site
AI
New York HQ
2mo ago
On-site
Full-time
General Application
On-site
Wildcard
New York HQ
1y ago
On-site
Full-time